Literature DB >> 12783462

Proteomic profiling of pancreatic ductal carcinoma cell lines treated with trichostatin-A.

Daniela Cecconi1, Aldo Scarpa, Massimo Donadelli, Marta Palmieri, Mahmoud Hamdan, Hubert Astner, Pier Giorgio Righetti.   

Abstract

A pancreatic adenocarcinoma cell line (Paca44) was treated with trichostatin-A (TSA), a potent inhibitor of histone deacetylases, in order to evaluate the effect of this drug on protein expression. Master maps of control and treated Paca44 cells were generated by analysis with the PDQuest software. The comparison between such maps showed up- and downregulation of 51 polypeptide chains, out of a total of 700 spots detected by a medium-sensitivity stain, micellar Coomassie Brilliant Blue. Fingerprinting by matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF)-mass spectrometry analysis enabled the identification of 22 of these spots. Among these proteins, of particular interest are the two downregulated proteins nucleophosmin and translationally controlled tumor protein, as well as the upregulated proteins programmed cell death protein 5 (also designated as TFAR19) and stathmin (oncoprotein 18). The modulation of these four proteins is consistent with our observation that TSA is able to inhibit cell growth of Paca44 by causing cell cycle arrest at the G2 phase and apoptotic cell death.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12783462     DOI: 10.1002/elps.200305430

Source DB:  PubMed          Journal:  Electrophoresis        ISSN: 0173-0835            Impact factor:   3.535


  6 in total

1.  Proteome analysis of human pancreatic ductal adenocarcinoma tissue using two-dimensional gel electrophoresis and tandem mass spectrometry for identification of disease-related proteins.

Authors:  Rui Tian; Li-Ming Wei; Ren-Yi Qin; Yan Li; Zhi-Yong Du; Wei Xia; Cheng-Jian Shi; Hong Jin
Journal:  Dig Dis Sci       Date:  2007-05-11       Impact factor: 3.199

Review 2.  Current evidence for histone deacetylase inhibitors in pancreatic cancer.

Authors:  Ioannis Koutsounas; Constantinos Giaginis; Efstratios Patsouris; Stamatios Theocharis
Journal:  World J Gastroenterol       Date:  2013-02-14       Impact factor: 5.742

Review 3.  Unfolding antifungals: as a new foe to pancreatic ductal adenocarcinoma-a mini-review.

Authors:  Shruti Gupta; Atul Kumar; Kiran Kumar Tejavath
Journal:  Mol Biol Rep       Date:  2021-04-01       Impact factor: 2.316

4.  Trichostatin A enhances the response of chemotherapeutic agents in inhibiting pancreatic cancer cell proliferation.

Authors:  Paolo Piacentini; Massimo Donadelli; Chiara Costanzo; Patrick S Moore; Marta Palmieri; Aldo Scarpa
Journal:  Virchows Arch       Date:  2006-03-28       Impact factor: 4.064

5.  Human histone chaperone nucleophosmin enhances acetylation-dependent chromatin transcription.

Authors:  V Swaminathan; A Hari Kishore; K K Febitha; Tapas K Kundu
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

6.  Experimental treatment of pancreatic cancer with two novel histone deacetylase inhibitors.

Authors:  Martin Haefner; Thilo Bluethner; Manuel Niederhagen; Christian Moebius; Christian Wittekind; Joachim Mossner; Karel Caca; Marcus Wiedmann
Journal:  World J Gastroenterol       Date:  2008-06-21       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.